These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 20225955)

  • 1. Host-pathogen interactions mediating pain of urinary tract infection.
    Rudick CN; Billips BK; Pavlov VI; Yaggie RE; Schaeffer AJ; Klumpp DJ
    J Infect Dis; 2010 Apr; 201(8):1240-9. PubMed ID: 20225955
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanisms of pain from urinary tract infection.
    Rosen JM; Klumpp DJ
    Int J Urol; 2014 Apr; 21 Suppl 1(0 1):26-32. PubMed ID: 24807489
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TRPV1 and the MCP-1/CCR2 Axis Modulate Post-UTI Chronic Pain.
    Rosen JM; Yaggie RE; Woida PJ; Miller RJ; Schaeffer AJ; Klumpp DJ
    Sci Rep; 2018 May; 8(1):7188. PubMed ID: 29739958
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipopolysaccharide Domains Modulate Urovirulence.
    Aguiniga LM; Yaggie RE; Schaeffer AJ; Klumpp DJ
    Infect Immun; 2016 Nov; 84(11):3131-3140. PubMed ID: 27528276
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bladder infection with uropathogenic
    Montalbetti N; Dalghi MG; Bastacky SI; Clayton DR; Ruiz WG; Apodaca G; Carattino MD
    Am J Physiol Renal Physiol; 2022 Jan; 322(1):F1-F13. PubMed ID: 34779263
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A live-attenuated vaccine for the treatment of urinary tract infection by uropathogenic Escherichia coli.
    Billips BK; Yaggie RE; Cashy JP; Schaeffer AJ; Klumpp DJ
    J Infect Dis; 2009 Jul; 200(2):263-72. PubMed ID: 19522648
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin-6/Stat3 signaling has an essential role in the host antimicrobial response to urinary tract infection.
    Ching CB; Gupta S; Li B; Cortado H; Mayne N; Jackson AR; McHugh KM; Becknell B
    Kidney Int; 2018 Jun; 93(6):1320-1329. PubMed ID: 29475562
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intramacrophage survival of uropathogenic Escherichia coli: differences between diverse clinical isolates and between mouse and human macrophages.
    Bokil NJ; Totsika M; Carey AJ; Stacey KJ; Hancock V; Saunders BM; Ravasi T; Ulett GC; Schembri MA; Sweet MJ
    Immunobiology; 2011 Nov; 216(11):1164-71. PubMed ID: 21802164
    [TBL] [Abstract][Full Text] [Related]  

  • 9. O-antigen modulates infection-induced pain states.
    Rudick CN; Jiang M; Yaggie RE; Pavlov VI; Done J; Heckman CJ; Whitfield C; Schaeffer AJ; Klumpp DJ
    PLoS One; 2012; 7(8):e41273. PubMed ID: 22899994
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of host innate immune response in the bladder by uropathogenic Escherichia coli.
    Billips BK; Forrestal SG; Rycyk MT; Johnson JR; Klumpp DJ; Schaeffer AJ
    Infect Immun; 2007 Nov; 75(11):5353-60. PubMed ID: 17724068
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of uropathogenic Escherichia coli outer membrane protein T in pathogenesis of urinary tract infection.
    He XL; Wang Q; Peng L; Qu YR; Puthiyakunnon S; Liu XL; Hui CY; Boddu S; Cao H; Huang SH
    Pathog Dis; 2015 Apr; 73(3):. PubMed ID: 25825479
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Virulence factors of uropathogenic E. coli and their interaction with the host.
    Lüthje P; Brauner A
    Adv Microb Physiol; 2014; 65():337-72. PubMed ID: 25476769
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rare emergence of symptoms during long-term asymptomatic Escherichia coli 83972 carriage without an altered virulence factor repertoire.
    Köves B; Salvador E; Grönberg-Hernández J; Zdziarski J; Wullt B; Svanborg C; Dobrindt U
    J Urol; 2014 Feb; 191(2):519-28. PubMed ID: 23911604
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular basis of uropathogenic Escherichia coli evasion of the innate immune response in the bladder.
    Billips BK; Schaeffer AJ; Klumpp DJ
    Infect Immun; 2008 Sep; 76(9):3891-900. PubMed ID: 18559433
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of O-Antigen Serotype with the Magnitude of Initial Systemic Cytokine Responses and Persistence in the Urinary Tract.
    Horvath DJ; Patel AS; Mohamed A; Storm DW; Singh C; Li B; Zhang J; Koff SA; Jayanthi VR; Mason KM; Justice SS
    J Bacteriol; 2016 Jan; 198(6):964-72. PubMed ID: 26755631
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Uropathogenic Escherichia coli induces extrinsic and intrinsic cascades to initiate urothelial apoptosis.
    Klumpp DJ; Rycyk MT; Chen MC; Thumbikat P; Sengupta S; Schaeffer AJ
    Infect Immun; 2006 Sep; 74(9):5106-13. PubMed ID: 16926402
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lack of association between the Tlr4 (Lpsd/Lpsd) genotype and increased susceptibility to Escherichia coli bladder infections in female C3H/HeJ mice.
    Suhs KA; Marthaler BR; Welch RA; Hopkins WJ
    mBio; 2011; 2(3):e00094-11. PubMed ID: 21628500
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Uropathogenic Escherichia coli Engages CD14-Dependent Signaling to Enable Bladder-Macrophage-Dependent Control of Acute Urinary Tract Infection.
    Carey AJ; Sullivan MJ; Duell BL; Crossman DK; Chattopadhyay D; Brooks AJ; Tan CK; Crowley M; Sweet MJ; Schembri MA; Ulett GC
    J Infect Dis; 2016 Feb; 213(4):659-68. PubMed ID: 26324782
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Androgens Enhance Male Urinary Tract Infection Severity in a New Model.
    Olson PD; Hruska KA; Hunstad DA
    J Am Soc Nephrol; 2016 Jun; 27(6):1625-34. PubMed ID: 26449605
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Uropathogenic Escherichia coli superinfection enhances the severity of mouse bladder infection.
    Schwartz DJ; Conover MS; Hannan TJ; Hultgren SJ
    PLoS Pathog; 2015 Jan; 11(1):e1004599. PubMed ID: 25569799
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.